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1. Introduction 
Around 100 billion neurons in the human nervous system orchestrate an exceptionally wide 
range of motor, sensory, regulatory, behavioural, and executive functions. Such diverse 
functional output is the product of different molecular events occurring in nervous cells and 
particularly, neurons. Morphologically, central nervous system (CNS) neurons differ in size, 
number and complexity of dendrites, number of synaptic connections, length of axons and 
distance across which synaptic connections are established, extent of axonal myelination, 
and other cellular characteristics. Neuronal diversity is also amplified by the inclusion of 
chemical specificity on the basis of the neurotransmitters, which they use for chemical 
transmission or neuromodulation. This great diversity among neuronal populations is a 
strong indication that although all neurons contain the same genetic code in their genome, 
each neuronal population has their own gene expression profile. While the diversity of 
neuronal structures and functions are well documented, what is less appreciated is the 
diverse response of neurons to stresses and adverse factors during aging or as a result of 
neurodegenerative diseases. Furthermore, to add complexity to an already heterogeneous 
landscape, non-neuronal populations, often described as a ‘supporting matrix’ are recently 
being recognized as active, information-rich, cellular counterpart in CNS function. 
In this scenario of cellular diversity emerges the concept of selective neuronal vulnerability 
(SNV). SNV is described as the differential sensitivity of neuronal populations in the 
nervous system to stresses that cause cell damage or death and can lead to 
neurodegeneration [1,2]. The fact that specific regions of the nervous system exhibit 
differential vulnerabilities to aging and various neurodegenerative diseases is a reflection of 
 Lipid Peroxidation 438 
both the specificity in the aetiology of each disease and of the heterogeneity in neuronal 
(and non-neuronal) responses to cell-damaging processes associated with each of the 
diseases [3]. The appearance of SNV is not limited to cross-regional differences in the 
nervous system, as within a single e.g. brain region, such as the hippocampus or the 
entorhinal cortex, where SNV is manifested as internal, sub-regional differences in relative 
sensitivities to stress and disease [2,3]. Among these cell-damaging processes one could 
count inflammatory, proteotoxicity, vascular and many other pathophysiological processes, 
including an excess of lipid peroxidation (see later). 
Oxidative stress (OS) is involved in the basic mechanisms of nervous system aging; whilst 
an excessive oxidation has been invoked as an etiopathogenic or physiopathologic 
mechanism for neurodegeneration. Oxidative stress, the result of an imbalance between 
production of free radicals and the enzymatic or non-enzymatic detoxification of these 
highly reactive species, is detrimental to cells because free radicals chemically modify lipids, 
proteins, and nucleic acids. So, it is very important to define the vulnerability of the different 
neuronal populations in terms of susceptibility to oxidative stress in physiological 
conditions in order to extent this knowledge to improve our understanding of how this 
particular form of cell vulnerability causes selective neuronal losses in nervous system, as 
well as reveal potential molecular and cellular mechanisms that bring about relative 
resistance or sensitivity of neurons to stresses. 
2. Mitochondrial free radical generation and membrane fatty acid 
composition in the CNS 
2.1. Mitochondrial free radical production 
Chemical reactions in cells of the nervous system are under strict enzyme control and 
conform to a tightly regulated metabolic program in order to minimize unnecessary side 
reactions. Nevertheless, apparently uncontrolled and potentially deleterious reactions occur, 
even under physiological conditions. Reactive oxygen species (ROS) express a variety of 
molecules and free radicals (chemical species with one unpaired electron) physiologically 
generated from the metabolism of molecular oxygen [4]. They are extremely reactive and 
have damaging effects. Superoxide anion, the product of a one-electron reduction of oxygen, 
is the precursor of most ROS and a mediator in oxidative chain reactions [4] (Figure 1). The 
character of radical is not circumscribed to oxygen containing species, as nitrogen, chloride 
and sulphide containing molecules could also play a significant role. Globally, in cells of the 
CNS the major sites of physiological ROS generation are the complex I and III of the 
mitochondrial electron transport chain, which contains several redox centers (flavins, iron–
sulphur clusters, and ubisemiquinone) capable of transferring one electron to oxygen to 
form superoxide anion [5,6]. Oxidative damage is a broad term used to cover the attack 
upon biological molecules by free radicals. ROS attack/damage all cellular constituents [6], 
but especially biological membranes. 
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Figure 1. The three main physiological ROS. CI, mitochondrial complex I; CIII, mitochondrial complex 
III; MnSOD, Manganese superoxide dismutase; Gpx, glutathione peroxidase. MnSOD and Gpx are 
antioxidants enzymes. 
2.2. Membrane fatty acid composition in neural cells 
All living organisms have lipid membranes. Biological membranes are dynamic structures 
that generally consist of bilayers of amphipathic molecules hold together by non-covalent 
bonds [7]. Phospholipids, consisting of a hydrophilic head group with attached hydrophobic 
acyl chains, are the predominant membrane lipids and are, from a topographic point of 
view, asymmetrically distributed across the bilayer. The variation in head groups and 
aliphatic chains allows the existence of a huge range of different phospholipid species [8,9]. 
The acyl chains are either saturated, monounsaturated or polyunsaturated hydrocarbon 
chains that normally vary from 14 to 22 carbons in length (Figure 2), with an average chain 
length strictly maintained around 18 carbon atoms, and a relative distribution between 
saturated and unsaturated fatty acids of 40:60 (SFA and UFA, respectively) [10]. 
Polyunsaturated fatty acids (PUFAs) are essential components of cellular membranes that 
strongly affect their fluidity, flexibility and selective permeability, as well as many cellular 
and physiological processes [11]. 
Long-chain polyunsaturated fatty acids are highly enriched in the nervous system. 
Docosahexaenoic acid (DHA; 22:6n-3; 4,7,10,13,16,19-C22:6), in particular, is the most 
abundant PUFA in the brain and is concentrated in aminophospholipids of cell membranes. 
Numerous studies have indicated that this concentration of DHA in the nervous system is 
essential for optimal neuronal functions. Although the underlying mechanisms of its 
essential function are still not clearly understood, emerging evidence suggests that unique 
metabolism of DHA in relation to its incorporation into neuronal membrane phospholipids 
plays an important role. 
Accretion of DHA in the CNS actively occurs during the developmental period, primarily 
relying on circulating plasma DHA derived from diet or from biosynthesis in the liver [12]. 
However, local biosynthesis of DHA also occurs in the brain, providing an alternative 
source of DHA for its accumulation in the brain [13]. It is well established that DHA can be 
biosynthesized from α-linolenic acid (18:3n-3; 9,12,15-C18:3), a shorter chain n-3 fatty acid 
precursor, through chain elongation and desaturation processes [14] (Figure 3). Linolenic  
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Figure 2. Fatty acid nomenclature. As an example, the structure of linoleic acid (C18:2n-6) is given. 
acid is desaturated to 18:4n-3 (6,9,12,15-C18:4) by Δ6-desaturase, chain-elongated to 20:4n-3 
(8,11,14,17-C20:4), and subsequently converted to eicosapentaenoic acid (20:5n-3; 
5,8,11,14,17-C20:5) by Δ5-desaturase in the endoplasmic reticulum (ER). Mammalian Δ5- 
and Δ6-desaturases have been identified and cloned [15]. However, Δ4-desaturase, 
responsible for making 22:6n-3 directly from 22:5n-3, an elongation product of 20:5n-3, has 
been identified only in microalgae [16]. In mammals, 22:5n-3 is further elongated to 24:5n-3 
(9,12,15,18,21-C24:5) followed by desaturation by Δ6-desaturase to 24:6n-3 (6,9,12,15,18,21-
C24:6). Subsequently, 24:6n-3 is transferred to peroxisomes and converted to 22:6n-3 by 
removing two carbon chains by β-oxidation. DHA thus formed is transferred back to the ER 
and quickly incorporated into membrane phospholipids by esterification during de novo 
synthesis or by a deacylation-reacylation reaction. Because biosynthesis of both fatty acids 
and phospholipids occurs in ER, a particular fatty acid intermediate can be either 
incorporated into phospholipids or further chain-elongated/desaturated, although the 
regulation of these processes is still poorly understood. Long-chain n-6 fatty acids are 
biosynthesized from linoleic acid (18:2n-6; 9,12-C18:2) using the analogous pathway and the 
same enzyme system (Figure 3). In most tissues, the commonly observed long-chain n-6 fatty 
acid is arachidonic acid (AA; 20:4n-6; 5,8,11,14-C20:4). Docosapentaenoic acid (DPAn-6; 
22:5n-6; 4,7,10,13,16-C22:5) produced by further elongation and desaturation of AA and 
subsequent peroxisomal β-oxidation, is rather a minor component, and yet it accumulates in 
the brain in place of DHA when the DHA supply is inadequate, especially during 
developmental periods. The distinctive fatty acid profile in the brain enriched with DHA or 
DPAn-6 may reflect the brain-specific uptake and/or regulation of fatty acid synthesis and 
esterification into membrane phospholipids. The liver is considered to be the primary site for 
biosynthesis of DHA, which becomes available to brain uptake through subsequent secretion 
into the circulating blood stream. Among neural cells, consisting of neurons, astrocytes, 
microglia, and oligodendrocytes, the capacity to synthesize DHA has been demonstrated 
only in astrocytes [13]. Despite the fact that neurons are major targets for DHA accumulation, 
they cannot produce DHA because of lack of desaturase activity. Cerebromicrovascular 
endothelia can also elongate and desaturate shorter carbon chain fatty acids. However, they 
cannot perform the final desaturation step to produce either 22:5n-6 or 22:6n-3 [17]. 
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Figure 3. Long chain and very long-chain fatty acid biosynthesis in mammals. The long chain saturated 
fatty acids and unsaturated fatty acids of the n-10, n-7 and n -9 series can be synthesized from palmitic 
acid (C16:0) produced by the fatty acid synthase (FAS). Long-chain fatty acids of the n-6 and n-3 series 
can only be synthesized from precursors obtained from dietary precursors (DIET). Elovl, elongation of 
very long chain fatty acids (fatty acid elongase); Fads, fatty acid desaturases. 
DHA synthesis in astrocytes is negatively influenced by the availability of preformed DHA 
[18] and thus may represent a quantitatively minor source for the neural DHA accretion 
when the circulating DHA supply is adequate. Incorporation of circulating DHA across the 
blood brain barrier appears to be an important route for maintaining adequate levels of 
DHA in the brain. In agreement with this notion, it has been shown that constant basal 
turnover of esterified DHA in the brain with unesterified DHA in plasma occurs at an 
estimated rate of 2–8% per day in adult rats [19]. Generally, it is difficult to deplete DHA 
from the neural membranes of adult mammals even with a DHA low diet, presumably 
because of preferential uptake of DHA into the brain to support the basal turnover. In the 
case of insufficient supply of n-3 fatty acids during development, the loss of DHA does 
occur but is compensated with DPAn-6 through reciprocal replacement, suggesting a 
requirement of very long-chain, highly unsaturated fatty acids in neural membranes. 
Whether brain DHA is derived from the circulating plasma pool or biosynthesized locally, 
in the astrocytes, which are situated in close contact with neurons, appear to play an 
important role in supplying DHA to neurons. DHA can be released readily from astroglial 
membranes under basal and stimulated conditions, and supplied to neurons. Despite its 
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high abundance in neuronal membranes, DHA is not easily released but is tenaciously 
retained in the neuronal membranes under the conditions in which AA can be released. 
Considering the fact that astroglia support neurons by providing neurotrophic factors, DHA 
supplied by astroglia may also be trophic. Indeed, DHA has been shown to promote 
neuronal survival [20] and differentiation [21] in both transformed and primary neuronal 
cells in culture. 
3. Membrane unsaturation and lipoxidation-derived molecular damage 
The susceptibility of membrane phospholipids to oxidative demise is related to two inherent 
traits, the physico-chemical properties of the membrane bilayer and the intrinsic chemical 
reactivity of the fatty acids composing the membrane [10,22]. The first property is related to 
the fact that oxygen and free radicals are more soluble in the fluid lipid bilayer than in the 
aqueous solution. Thus, membranes contain an interior organic phase in which the oxygen 
may tend to concentrate. Therefore, these differences in solubility are important when 
considering the availability of oxygen/free radicals for chemical reactions inside living 
systems: organic regions may contain more free radicals than aqueous regions [8] and, 
consequently, membrane lipids become primary targets of oxidative damage. The second 
property is related to the fact that PUFA residues of phospholipids are extremely sensitive 
to oxidation. Every membrane phospholipid contains an unsaturated fatty acid residue 
esterified to the 2-hydroxyl group of its glycerol moiety. Many of these are polyunsaturated 
and the presence of a methylene group between two double bonds renders the fatty acid 
more sensitive to ROS-induced damage. Therefore, the sensitivity of these molecules to 
oxidation increase exponentially as a function of the number of double bonds per fatty acid 
molecule [22,23]. Consequently, the high concentration of PUFAs in phospholipids not only 
makes them prime targets for reaction with oxidizing agents but also enables them to 
participate in long free radical chain reactions. Reactive free radicals can pull off hydrogen 
atoms from PUFA side chains. A hydrogen atom (H) has only one electron. This hydrogen 
is bonded to a carbon in the fatty acid backbone by a covalent bond. Hence, the carbon from 
which H is abstracted now has an unpaired electron (i.e it is a free radical). PUFA side 
chains (two or more double bonds) are more sensitive to attack by radicals than are SFAs 
(no double bonds) or monounsaturated fatty acids (MUFA,one double bond) side chains. 
When C radicals are generated in the hydrophobic interior of membranes, their most likely 
fate is combination with oxygen dissolved in the membrane. The resulting peroxyl radical is 
highly reactive: it can attack membrane proteins and oxidize adjacent PUFA side chains. So, 
the reaction is repeated and the whole process continues in a free radical chain reaction, 
generating lipid hydroperoxides [4]. Lipid hydroperoxides are more hydrophilic than 
unperoxidized fatty acid side chains. They try to migrate to the membrane surface to 
interact with water, thus disrupting the membrane structure, altering fluidity and other 
functional properties and making the membrane leaky. 
Lipid peroxidation generates hydroperoxides as well as endoperoxides, which undergo 
fragmentation to produce a broad range of reactive intermediates called reactive carbonyl 
species (RCS) (Figure 4) with three to nine carbons in length, the most reactive being α,β-
 
Region Specific Vulnerability to Lipid Peroxidation in the Human Central Nervous System  443 
unsaturated aldehydes [4-hydroxy-trans-2-nonenal (HNE) and acrolein], di-aldehydes 
[malondialdehyde (MDA) and glyoxal], and keto-aldehydes [4-oxo-trans-2-nonenal (ONE) 
and isoketals] [24]. 2-Hydroxyheptanal (2-HH) and 4-hydroxyhexenal (4-HHE) are 
aldehydic product of lipid peroxidation of PUFAn-6. Additionally, a number of other short 
chain aldehydes are produced during lipid peroxidation through poorly understood 
mechanisms. These carbonyl compounds, ubiquitously generated in biological systems, 
have unique properties contrasted with free radicals. Thus, compared with reactive oxygen 
and nitrogen species, reactive aldehydes have a much longer half-life (i.e., minutes to hours 
instead of microseconds to nanoseconds for most free radicals). Further, the non-charged 
structure of aldehydes allows them to migrate relatively ease through hydrophobic 
membranes and hydrophilic cytosolic media, thereby extending the migration distance far 
from the production site. Based on these features alone, these carbonyl compounds can be 
more destructive than ROS and may have far-reaching damaging effects on target sites 
within or outside membranes. For the same reason, their long half-life allows them to 
subserve as second-messenger, signalling for important cellular responses in a mostly 
unknown fashion.  
 
Figure 4. General structures of principal lipoxidative reactive carbonyl species detected in biological 
systems. 
Carbonyl compounds react with nucleophilic groups in macromolecules like proteins, DNA, 
and aminophospholipids, among other, resulting in their chemical, nonenzymatic, and 
irreversible modification and formation of a variety of adducts and crosslinks collectively 
named Advanced Lipoxidation Endproducts (ALEs) [10,25,26] (Figure 5) . Thus, by reacting 
with nucleophilic sites in proteins (belonging basically to Cys, Lys, Arg, and His residues), 
carbonyl compounds generate ALE adducts such as MDA-Lys, HNE-Lys, FDP-Lys, 
carboxymethyl-lysine (CML) and S-carboxymethyl-cysteine; and the crosslinks glyoxal-
lysine dimer (GOLD), and methylglyoxal-lysine dimer (MOLD), among several others. The 
accumulation of MDA adducts on proteins is also involved in the formation of lipofuscin (a 
nondegradable intralysosomal fluorescent pigment formed through lipoxidative reactions). 
Lipid peroxidation-derived endproducts can also react at the exocyclic amino groups of 
deoxyguanosine, deoxyadenosine, and deoxycytosine to form various alkylated products. 
Guanine is, however, the most commonly modified DNA base because of its high 
nucleophilicity. Some common enals that cause DNA damage, analogously to proteins, are  
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Figure 5. Reactive carbonyl species react with nucleophilic groups in macromolecules (A, proteins; B, 
DNA) resulting in their chemical, nonenzymatic, and irreversible modification and formation of a 
variety of adducts and crosslinks collectively named Advanced Lipoxidation Endproducts (ALEs).\ 
 
Region Specific Vulnerability to Lipid Peroxidation in the Human Central Nervous System  445 
MDA, HNE, and acrolein, among others. Thus, the most common adducts arising from 
enals are exocyclic adducts such as etheno adducts, and MDA-deoxyguanosine (M1dG). 
Finally, the amino group of aminophospholipids can also react with carbonyl compounds 
and initiate some of the reactions ocurring in proteins and DNA, leading to the formation of 
adducts like MDA-phosphatidylethanolamine, and carboxymethyl-
phosphatidylethanolamine [10]. 
4. ALEs: Molecular and cellular effects 
Reactive carbonyl species (RCS) generated during lipid peroxidation reactions exhibit a 
wide range of molecular and biological effects, ranging from protein, DNA, and 
phospholipid damage to signaling pathway activation and/or alteration. The detailed 
mechanisms of ‘toxicity’ are, however, mostly unknown. 
4.1. Molecular damage 
Lipoxidation reactions lead to structural and functional changes in proteins [25-27] such as i) 
alterations in physico-chemical properties (conformation, charge, hydrophobicity, elasticity, 
solubility, and electrophoretic mobility, among others); ii) decrease/inhibition in enzyme 
activity and growth factors; iii) alteration of protein degradation; iv) alteration in traffic and 
processing of proteins; and v) formation of intra- and inter-molecular protein cross-links 
and aggregates.  
DNA lipoxidative damage is present in the genome of healthy humans and other animal 
species at biologically significant levels similar or even higher that oxidation markers sensu 
stricto. DNA damage is mutagenic, carcinogenic, and have powerful effects on signal 
transduction pathways [28]. 
Finally, the amino group of aminophospholipids can also react with carbonyl compounds 
and initiate some of the reactions occurring in proteins [29]. Biological processes involving 
aminophospholipids could be potentially affected by this process. Among these processes, it 
may be highlighted i) asymmetrical distribution of aminophospholpids in cellular and 
different subcellular membranes; ii) translocation between and lateral diffusion in the 
membrane; iii) membrane physical properties; iv) biosynthesis and turnover of membrane 
phospholipids; and v) activity of membrane-bound proteins that require 
aminophospholipids for their function. 
4.2. Cellular adaptive responses  
The peroxidation of the PUFA chains of phospholipids generates a complex mixture of 
carbonyl compounds. Initially, these aldehydes were believed to produce only “cytotoxic” 
effects associated with oxidative stress (by inducing molecular damage and damaging 
cellular responses based on inflammatory responses, changes in gene expression and 
apoptosis) [10], but as depicted above, evidence is increasing in the sense that these 
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compounds can also have specific signaling roles inducing adaptive responses driven to 
decrease oxidative damage and improve antioxidant defences. 
Thus, available studies support the notion that superoxide radical produced by the 
mitochondrial electron transport chain can cause mild uncoupling of mitochondria by 
activating the membrane proton conductance by uncoupling proteins (UCPs). Insight into 
the molecular mechanism by which superoxide radical activates UCPs comes from the 
finding that the lipid peroxidation product 4-HNE and its homologs induce uncoupling of 
mitochondria through UCPs and also through the adenine nucleotide translocase [30]. This 
and other observations support a model in which endogenous superoxide production 
generates carbon-centred radicals that initiate lipid peroxidation, producing alkenals like 4-
HNE that activate UCPs and adenine nucleotide translocase. So, UCPs respond to 
overproduction of matrix superoxide by catalyzing mild uncoupling, which lower proton 
motive force and would decrease superoxide production by the electron transport chain. 
This negative feedback loop will protect cells from ROS-induced damage and might 
represent the ancestral function of all UCPs. 
In addition, RCS can also activate the ‘antioxidant response’ likely to prevent their 
accumulation to toxic levels [31]. This signaling cascade culminates in the nuclear 
translocation of and transactivation by the transcription factor Nrf2, the master regulator of 
the response [32]. Nrf2 activity is repressed by an inhibitory binding protein, Keap1. Keap1 
retains Nrf2 in the cytosol, closely associated with the actin cytoskeleton, and promotes 
proteasomal degradation of Nrf2 through Cullin3-dependent polyubiquitination. Following 
exposure to RCS, Keap1 can be directly modified on several cysteine residues, and this 
modification can promote release of Nrf2. Nrf2 contains a C-terminal basic leucine zipper 
structure that facilitates dimerization and DNA binding, specifically to the antioxidant 
response element (ARE). The binding of Nrf2 to the ARE stimulates transcription of 
downstream cytoprotective genes [32].  
5. The selective neuronal vulnerability 
The idea that oxygen radicals, especially those of mitochondrial origin, are causally related 
to the basic aging process is increasingly receiving support from several independent 
sources [reviewed in 6,33]. Accordingly, the mitochondrial oxygen radical theory of aging 
apparently fulfils the main characteristics of this natural process: reactive oxygen species 
(ROS) are endogenously produced at mitochondria under normal physiological conditions, 
they are produced continuously throughout life (and can thus lead to progressive aging 
changes), and their deleterious effects on macromolecules may inflict irreversible damage 
during aging in post-mitotic tissues.  The detrimental effects of aging are best observed in 
postmitotic tissues because cells that are irreversibly damaged or lost cannot be replaced by 
mitosis of intact ones. Nervous system is considered a postmitotic tissue, and therefore 
highly susceptible to aging. As this process is involved as a risk factor in most 
neurodegenerative diseases, and oxidative modifications play a key role in aging, it is often 
accepted that these diseases should have increased oxidative damage. 
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In this context, and from an inter-organ comparative approach, two main properties emerge 
as characteristics that render nervous system as especially sensible to oxidative 
modification: i) the % free radical leak, and ii) the membrane unsaturation. The % free 
radical leak (%FRL) refers the fraction (%) of electrons out of sequence which reduce oxygen 
to oxygen radicals (instead of reducing oxygen to water at cytochrome oxidase) in the 
mitochondrial respiratory chain. Since two electrons are needed to reduce one molecule of 
oxygen to H2O2, whereas four electrons are needed to reduce one molecule of oxygen to 
water, the free radical leak is easily calculated by dividing the rate of ROS production by 2 
times the rate of oxygen consumption, the result being multiplied by 100. Results show that 
the higher %FRL corresponds to brain, suggesting that mitochondria are more inefficient in 
this tissue than in other organs (Tables 1 and 2, and Figure 6). 
 
  Brain Heart Kidney Liver 
Skeletal 
muscle 
Pyruvate/malate State 4 11.2 ± 1.7 28.4 ± 4.7 - 7.8 ± 1.0 22 ± 3 
 State 3 23.1 ± 3.0 72.2 ± 5.4 - 19.5 ± 2.4 127 ± 18 
Glutamate/malate State 4 11.5 ± 2.1 - 23.2 ± 4.2 9.4 ± 0.8 - 
 State 3 23.6 ± 4.1 - 88.1 ± 13.4 72.1 ± 5.3 - 
Succinate/rotenone State 4 15.8 ± 1.6 85.8 ± 9.4 55.6 ± 11.6 26.2 ± 2.0 97 ± 12 
 State 3 24.0 ± 2.0 112. ± 5.3 148.1 ± 27.0 100.9 ± 9.1 239 ± 34 
Values are mean ± SEM from 8 different animals. State 4, oxygen consumption in the absence of ADP; State 3, oxygen 
consumption in the presence of ADP. Data from references: 34-36 and unpublished results. 
Table 1. Rates of mitochondrial oxygen consumption (nmoles of O2/ min .mg protein) of different 
organs from male adult rats. 
 
Substrate Brain Heart Kidney Liver Skeletal muscle 
Pyr/mal 0.2 ± 0.04 0.24 ± 0.04 - 0.06 ± 0.01 0.084 ± 0.020 
Pyr/mal + Rot 1.05 ± 0.13 1.49 ± 0.12 - 0.38 ± 0.04 0.73 ± 0.14 
Glut/mal 0.17 ± 0.04 - 0.075 ± 0.05 0.16 ± 0.02 - 
Glut/mal + Rot 0.72 ± 0.10 - 0.66 ± 0.12 0.46 ± 0.04 - 
Succ + Rot 0.26 ± 0.05 0.51 ± 0.05 0.10 ± 0.04 0.32 ± 0.04 0.31 ± 0.06 
Succ 1.72 ± 0.17 0.71 ± 0.12 0.52 ± 0.08 1.00 ± 0.18 1.57±0.31 
Succ + AA 2.67 ± 0.31 - 5.97 ± 0.45 3.00 ± 0.41 2.57± 0,30 
Values are means ± SEM from 8 different animals. Pyr/mal = pyruvate/malate; Glu/mal = glutamate/malate; Succ, 
succinate; Rot, rotenone; AA, antimycin A. Data from references: 34-36 and unpublished results. 
Table 2. Rates of mitochondrial H2O2 production (nanomoles H2O2/min  mg protein) of different organs 
from male adult rats. 
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Figure 6. % Free radical leak (% FRL) of different organs from male adult rats. Data from references: 34-
36 and unpublished results. 
As mentioned above, the susceptibility of biological membranes to oxidative alterations is 
related to two inherent traits, the physico-chemical properties of the lipid bilayer and the 
chemical reactivity of the fatty acids which make up the membrane. Table 3 shows the 
mitochondrial fatty acid composition (mol%) of different organs. Data clearly indicate that 
average chain length is maintained around 18 carbon atoms and that the % 
saturated:unsaturated follows the ratio around 40:60. By contrast, the more relevant  
 
Figure 7. Steady-state level of mitochondrial lipoxidative-derived protein damage in different organs 
from male adult rats. MDAL, malondialdehyde-lysine. Units: μmol/mol lysine. 
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differences are droved to the distribution of the different types of PUFAs. Thus, brain is 
characterized by the presence of the higher content of monounsaturated fatty acids, as well 
as PUFAn-3, and particularly, the docosahexaenoic acid (22:6n-3) compared to the other 
postmitotic organs (Table 3). This higher PUFAs content which are more susceptible to 
oxidative damage leads to a higher steady-state level of lipoxidation-derived molecular 
damage at least at mitochondrial level (Figure 7).  
 
 Brain Heart Kidney Liver Skeletal muscle 
14:0 0.14±0.03 1.17±0.03 0.36±0.03 0.18±0.01 0.82±0.14 
16:0 10.55±0.46 22.68±0.60 10.00±0.38 17.31±0.44 20.39±0.45 
16:1n-7 0.28±0.02 0.91±0.04 0.48±0.09 1.11±0.07 0.67±0.05 
18:0 18.12±0.39 26.49±0.34 12.67±0.56 17.19±0.24 18.34±0.73 
18:1n-9 24.78±0.31 13.23±0.39 8.97±0.44 9.09±0.17 8.44±0.98 
18:2n-6 1.55±0.07 9.27±0.42 14.10±0.42 19.27±0.66 17.73±1.23 
18:3n-3 0.12±0.03 0.38±0.01 0.47±0.11 0.18±0.04 0.80±0.12 
18:4n-6 2.38±0.08 0.11±0.01 4.67±0.40   
20:0 1.05±0.07 0.20±0.01 0.51±0.07   
20:1n-9 4.12±0.18 0.19±0.02 0.69±0.09   
20:2n-6 0.52±0.05 0.97±0.14 0.92±0.06 0.35±0.01  
20:3n-6 0.10±0.01 0.79±0.06 0.38±0.03 0.27±0.02  
20:4n-6 12.74±0.13 15.69±0.45 36.32±1.21 26.61±0.44 13.96±0.79 
20:5n-3 0.14±0.01 0.15±0.01 0.40±0.07 0.35±0.02 1.66±0.44 
22:0 1.57±0.26 0.21±0.02 2.24±0.16   
22:4n-6 4.19±0.16 0.73±0.06 0.46±0.02 0.16±0.008 1.54±0.35 
22:5n-6 0.68±0.03 1.40±0.22 0.46±0.04 0.28±0.04 1.99±0.23 
22:5n-3 2.00±0.16 0.84±0.04 1.56±0.11 0.79±0.04 2.95±0.23 
22:6n-3 12.81±0.33 4.28±0.26 1.81±0.19 6.79±0.44 10.65±0.96 
24:0 0.14±0.04 0.25±0.04 0.27±0.04   
24:5n-3 0.26±0.07  0.93±0.22   
24:6n-3 1.65±0.16  1.24±0.28   
ACL 19.12±0.05 18.15±0.03 18.97±0.03 18.49±0.01 18.54±0.02 
SFA 31.61±0.52 51.02±0.71 26.07±0.62 34.69±0.50 39.56±1.04 
UFA 68.38±0.52 48.97±0.71 73.92±0.62 65.30±0.50 60.43±1.04 
MUFA 29.19±0.32 14.34±0.44 10.15±0.51 10.20±0.18 9.11±1.01 
PUFA 39.19±0.73 34.63±0.94 63.77±1.07 55.09±0.56 51.32±1.41 
PUFAn-6 22.18±0.20 28.97±0.92 57.33±1.16 46.97±0.95 36.91±1.18 
PUFAn-3 17.00±0.57 5.66±0.25 6.43±0.32 8.12±0.41 14.41±0.88 
Values: mean±SEM. N x group: 8. ACL, average chain length; SFA, saturated faaty acids; UFA, unsaturated fatty acids; 
PUFA n-6/n-3, polyunsaturated fatty acids n-6 or n-3 series; MUFA, monounsaturated fatty acids. Data from 
references: 34-36 and unpublished results. 
Table 3. Mitochondrial fatty acid composition (mol%) of different organs from male adult rats. 
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Compared to other postmitotic organs, brain seems to be the tissue more susceptible to 
oxidative damage. However, are there cross-regional differences in the nervous system? 
Available data seems to indicate that this is the case. Thus, Table 4 reflects the fatty acid 
composition in seven different regions from human nervous system samples. The data are 
conclusive: despite to maintain a stable average chain length (around 18 carbon atoms) and 
a ratio saurated:unsaturated practically identical (40:60), there is a cross-regional difference 
with respect to the type of PUFA distribution affecting very specially to both 
monounsaturated and polyunsaturated fatty acids that seems to be inversely related. In 
other words, the higher the presence of monounsaturated fatty acids for a given region, the 
lower the PUFA content. The meaning of this differential distribution remains to be 
elucidated, but it is evident that determine a differential susceptibility to oxidative damage. 
 
 
Frontal
Cortex 
Occipital
Cortex 
Hippocampus Amygdala
Substantia
Nigra 
Medulla 
Oblongata 
Spinal 
Cord 
14:0 0.51±0.04 0.54±0.05 0.42±0.05 0.56±0.05 0.54±0.04 0.50±0.04 0.48±0.05 
16:0 21.13±0.51 20.30±1.70 19.54±0.27 20.69±0.67 12.68±0.39 13.57±0.38 14.75±0.25 
16:1n-7 0.98±0.12 0.76±0.19 0.89±0.10 1.48±0.12 1.68±0.18 1.21±0.03 0.94±0.06 
18:0 21.35±1.23 19.23±0.41 21.89±0.20 20.19±0.67 24.61±0.27 25.64±0.61 22.07±1.72 
18:1n-9 23.78±1.51 28.57±1.16 26.12±0.50 28.40±0.77 33.57±0.19 30.13±0.87 33.51±1.43 
18:2n-6 0.77±0.12 0.57±0.07 0.59±0.04 0.53±0.09 0.33±0.06 0.56±0.01 0.96±0.61 
18:3n-3 0.14±0.01 0.21±0.04 0.23±0.02 0.08±0.006 0.17±0.003 0.23±0.01 0.34±0.05 
20:0 1.25±0.23 2.40±0.52 1.44±0.09 1.71±0.12 4.95±0.12 5.58±0.23 7.62±0.53 
20:1 0.19±0.04 0.32±0.05 0.37±0.01 0.28±0.02 0.22±0.02 0.45±0.02 0.75±0.09 
20:2n-6 0.23±0.01 0.22±0.01 0.23±0.02 0.20±0.02 0.23±0.03 0.31±0.06 0.28±0.01 
20:3n-6 0.63±0.07 0.64±0.04 0.90±0.10 0.60±0.08 0.61±0.02 0.99±0.03 0.87±0.16 
20:4n-6 8.28±0.19 6.07±0.35 8.05±0.24 7.42±0.42 3.70±0.29 3.95±0.33 3.13±0.09 
22:4n-6 4.77±0.14 5.06±0.69 6.24±0.20 4.79±0.27 4.32±0.15 4.07±0.08 3.16±0.17 
22:5n-6 0.67±0.09 0.59±0.09 0.92±0.08 0.94±0.11 0.12±0.007 0.40±0.02 0.24±0.04 
22:5n-3 0.26±0.03 0.19±0.02 0.33±0.02 0.13±0.04 0.06±0.006 0.09±0.01 0.38±0.14 
22:6n-3 13.68±0.17 13.71±0.71 10.97±0.31 9.99±0.58 9.74±0.28 9.28±0.45 8.84±0.71 
24:0 0.38±0.06 0.31±0.05 0.45±0.04 0.47±0.03 0.64±0.06 1.19±0.22 1.00±0.08 
24:1n-9 0.93±0.23 0.21±0.03 0.33±0.04 1.46±0.32 1.73±0.18 1.75±0.11 0.59±0.10 
        
ACL 18.60±0.01 18.56±0.04 18.58±0.008 18.48±0.04 18.59±0.005 18.64±0.03 18.52±0.01 
SFA 44.64±1.33 42.80±0.74 43.77±0.37 43.65±0.94 43.43±0.34 46.51±0.47 45.95±1.81 
UFA 55.35±1.33 57.19±0.74 56.22±0.37 56.34±0.94 56.56±0.34 53.48±0.47 54.04±1.81 
MUFA 25.90±1.70 29.88±1.11 27.74±0.52 31.62±1.05 37.22±0.24 33.56±0.92 35.80±1.53 
PUFA 29.45±0.46 27.31±0.38 28.48±0.25 24.71±1.02 19.33±0.42 19.92±0.45 18.24±0.43 
PUFAn-6 15.36±0.36 13.18±0.25 16.95±0.36 14.49±0.66 9.34±0.26 10.30±0.30 8.67±0.81 
PUFAn-3 14.08±0.18 14.12±0.63 11.53±0.34 10.21±0.59 9.99±0.28 9.61±0.46 9.57±0.57 
Values: mean±SEM. N x group: 3-9.  ACL, average chain length; SFA, saturated faaty acids; UFA, unsaturated fatty 
acids; PUFA n-6/n-3, polyunsaturated fatty acids n-6 or n-3 series; MUFA, monounsaturated fatty acids.  
(#) Unpublished results.  
Table 4. Fatty acid composition (mol%) in the human nervous system: a cross-regional comparative 
approach #. 
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This means that saturated and monounsaturated fatty acyl chains (SFA and MUFA) are 
essentially resistant to peroxidation while polyunsaturates (PUFA) are damaged. 
Furthermore the greater the degree of polyunsaturation of PUFA the more prone it is to 
peroxidative damage. Indeed Holman [23] empirically determined (by measurement of 
oxygen consumption) the relative susceptibilities the different acyl chains (see Figure 8): 
Docosahexaenoic acid (DHA), the highly polyunsaturated omega-3 PUFA with six double 
bonds is extremely susceptible to peroxidative attack and is eight-times more prone to 
peroxidation than linoleic acid (LA) which has only two double bonds. DHA is 320-times 
more susceptible to peroxidation than the monounsaturated oleic acid (OA) [22,23].  
 
Figure 8. The relative susceptibilities of selected unsaturated fatty acids to peroxidation. Data are from 
[23], and all were empirically determined as rates of oxygen consumption. They are expressed relative 
to the rate for linoleic acid (18:2n-6) which is arbitrarily given a value of 1. 
Combining the relative susceptibilities of different fatty acids with the fatty acid 
composition of membrane lipids it is possible to calculate a peroxidizability index1 (a 
measure of the susceptibility to peroxidation) for any particular membrane. The 
peroxidation index of a membrane is not the same as its unsaturation index (sometimes also 
called its “double bond index”) which is a measure of the density of double bonds in the 
membrane. For example, a membrane bilayer consisting solely of MUFA will have an 
unsaturation index of 100 and a peroxidation index of 2.5, while a membrane bilayer 
consisting of 95% SFA and 5% DHA will have an unsaturation index of 30 and a 
peroxidation index of 40. This means that although the 5% DHA-containing membrane has 
only 30% the density of double bonds of the monounsaturated bilayer, it is 16-times more 
susceptible to peroxidative damage. In this context, data clearly show the existence of very 
important cross-regional differences in peroxidizability index in human central nervous 
system (Figure 9). 
                                                                
1 [Peroxidizability Index (PI) = 0.025 x (% monoenoics) + 1 x (% dienoics) + 2 x (% trienoics) + 4 x (% tetraenoics) + 6 x (% 
pentaenoics) + 8 x (% hexaenoics),   while  Unsaturation index (UI) = 1 x (% monoenoics) + 2 x (% dienoics) + 3 x (% trienoics) + 
4 x (% tetraenoics) + 5 x (% pentaenoics) + 6 x (% hexaenoics) ]    
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The different cross-regionally PIs observed are due to changes in the type of unsaturated 
fatty acid that participates in membrane composition. So, there is a systematic redistribution 
between the types of PUFAs present from highly unsaturated fatty acids to the less 
unsaturated that is region-specific. Surprisingly, the change shows a gradient that follows 
the cranio-caudal axis considering the structural organization of the CNS. The mechanism(s) 
responsible for the cross-regional-related differences in fatty acid profile can be related, in 
principle, to the fatty acid desaturation pathway, and the deacylation-reacylation cycle. The 
available delta-5 and delta-6 estimated desaturase activities indicate that they are several 
folds higher in frontal cortex than in spinal cord (Figure 10). The mechanism underlying to 
the membrane unsaturation regulation could explain the differences in membrane fatty acid 
composition and, in turn, the peroxidizability index, and suggest a regulatory mechanism 
region-specific that is expressed differentially in a cranio-caudal axis likely associated to the 
development process and even the evolution of the central nervous system. 
 
Figure 9. Cross-regional differences in the peroxidizability index in the human central nervous system. 
FC, frontal cortex; OC, occipital cortex; HC, hippocampus; AM, amygdala; SN, substantia nigra; MO, 
medulla oblongata; SC, spinal cord. 
 
Figure 10. Delta-5 and delta-6 desaturase activities in different regions of the human central nervous 
system. FC, frontal cortex; OC, occipital cortex; HC, hippocampus; AM, amygdala; SN, substantia nigra; 
MO, medulla oblongata; SC, spinal cord. 
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In summary, membrane unsaturation is a key characteristic able to define the selective 
neuronal vulnerability. In this context, it is plausible to postulate that membrane 
unsaturation could be a main determinant factor in determining differences in the rate of 
aging for different regions of the CNS, and in the occurrence of neurodegenerative disorders 
[e.g., Alzheimer’s disease (AD), Parkinson’s disease (PD), or amyotrophic lateral sclerosis 
(ALS), among others] during the sixth, seventh and eighth decades of life. Interestingly, 
this property is also causally related to the aging process and the lifespan of animal species 
[6]. 
6. Conclusions and perspectives  
A major goal of research into aging is to extend ‘healthspan’ by identifying approaches for 
delaying or preventing age-related diseases. The fact that many individuals maintain a well-
functioning nervous system and continue productive lives through their seventies, eighties 
and even nineties is encouraging. The implication is that if the cellular and molecular 
mechanisms that determine whether nervous systems adapt positively or develop a disease 
during aging can be identified, then disease processes can be averted. In this regard, 
oxidative and metabolic stress and impaired cellular stress adaptation, are mechanisms of 
aging that render neurons vulnerable to degeneration. On this background of age-related 
endangerment, genetic and environmental factors likely determine whether a disease 
process develops. These include causal mutations, more subtle genetic risk factors and 
environmental factors, including aspects of diet and lifestyle. Because of the cellular and 
molecular complexity of the nervous system, and the signalling mechanisms that influence 
neuronal plasticity and survival, the basis of SNV remains elusive. However, available 
evidence from both an inter-organ comparative approach and cross-regional differences 
seems to confirm this idea, highlighting membrane unsaturation as a key trait associated 
with selective neuronal vulnerability. Interestingly, this property is also causally related to 
the aging process and the lifespan of animal species [6,10], and it is apparently operative in 
multiple neurodegenerative disorders [3,37]. Currently, most efforts to prevent and treat 
neurodegenerative disorders are focusing on diet, on lifestyle modification, and on drugs 
that target disease processes [3,6,33]. Although data on humans is still limited, the emerging 
evidence that dietary restriction (along with exercise and cognitive stimulation) can bolster 
neuroprotective mechanisms suggests that diet and lifestyle changes could reduce the risk of 
neurodegenerative disorders [6,26,33]. Therefore, it seems likely that extension of neural 
healthspan is possible for most individuals. 
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